197 related articles for article (PubMed ID: 27227356)
1. Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis.
Zheng S; Wang R; Zhang Y; Pan Y; Cheng C; Zheng D; Sun Y; Chen H
Cancer Med; 2016 Aug; 5(8):2117-25. PubMed ID: 27227356
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.
Okamoto T; Suzuki Y; Fujishita T; Kitahara H; Shimamatsu S; Kohno M; Morodomi Y; Kawano D; Maehara Y
Lung Cancer; 2014 Aug; 85(2):125-30. PubMed ID: 24976334
[TBL] [Abstract][Full Text] [Related]
3. Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.
Ferketich AK; Niland JC; Mamet R; Zornosa C; D'Amico TA; Ettinger DS; Kalemkerian GP; Pisters KM; Reid ME; Otterson GA
Cancer; 2013 Feb; 119(4):847-53. PubMed ID: 23023590
[TBL] [Abstract][Full Text] [Related]
4. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
Bryant A; Cerfolio RJ
Chest; 2007 Jul; 132(1):185-92. PubMed ID: 17573517
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study.
Löfling L; Karimi A; Sandin F; Bahmanyar S; Kieler H; Lambe M; Lamberg K; Wagenius G
Acta Oncol; 2019 Nov; 58(11):1618-1627. PubMed ID: 31373239
[No Abstract] [Full Text] [Related]
6. The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.
Muallaoglu S; Karadeniz C; Mertsoylu H; Ayberk Besen A; Sezer A; Murat Sedef A; Kose F; Ozyilkan O
J BUON; 2014; 19(2):453-8. PubMed ID: 24965406
[TBL] [Abstract][Full Text] [Related]
7. Non-small cell lung cancer in never smokers: a clinical entity to be identified.
Santoro IL; Ramos RP; Franceschini J; Jamnik S; Fernandes AL
Clinics (Sao Paulo); 2011; 66(11):1873-7. PubMed ID: 22086516
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.
Meguid RA; Hooker CM; Harris J; Xu L; Westra WH; Sherwood JT; Sussman M; Cattaneo SM; Shin J; Cox S; Christensen J; Prints Y; Yuan N; Zhang J; Yang SC; Brock MV
Chest; 2010 Sep; 138(3):500-9. PubMed ID: 20507946
[TBL] [Abstract][Full Text] [Related]
9. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer.
Janjigian YY; McDonnell K; Kris MG; Shen R; Sima CS; Bach PB; Rizvi NA; Riely GJ
Cancer; 2010 Feb; 116(3):670-5. PubMed ID: 20029977
[TBL] [Abstract][Full Text] [Related]
10. Proportion and clinical features of never-smokers with non-small cell lung cancer.
Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS
Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.
Kerr KM; Dafni U; Schulze K; Thunnissen E; Bubendorf L; Hager H; Finn S; Biernat W; Vliegen L; Losa JH; Marchetti A; Cheney R; Warth A; Speel EJ; Blackhall F; Monkhorst K; Jantus Lewintre E; Tischler V; Clark C; Bertran-Alamillo J; Meldgaard P; Gately K; Wrona A; Vandenberghe P; Felip E; De Luca G; Savic S; Muley T; Smit EF; Dingemans AC; Priest L; Baas P; Camps C; Weder W; Polydoropoulou V; Geiger TR; Kammler R; Sumiyoshi T; Molina MA; Shames DS; Stahel RA; Peters S;
Ann Oncol; 2018 Jan; 29(1):200-208. PubMed ID: 29186353
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of smoking status in operated non-small cell lung cancer.
Sardari Nia P; Weyler J; Colpaert C; Vermeulen P; Van Marck E; Van Schil P
Lung Cancer; 2005 Mar; 47(3):351-9. PubMed ID: 15713518
[TBL] [Abstract][Full Text] [Related]
13. Impact of current versus former smoking status on the outcomes of non-metastatic non-small cell lung cancer treated with upfront surgery; findings from the National Lung Screening Trial.
Abdel-Rahman O
Expert Rev Respir Med; 2019 Jun; 13(6):585-591. PubMed ID: 31055993
[No Abstract] [Full Text] [Related]
14. Lung cancer in never-smokers - what are the differences?
Dias M; Linhas R; Campainha S; Conde S; Barroso A
Acta Oncol; 2017 Jul; 56(7):931-935. PubMed ID: 28514931
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.
Ng TL; Liu Y; Dimou A; Patil T; Aisner DL; Dong Z; Jiang T; Su C; Wu C; Ren S; Zhou C; Camidge DR
Cancer; 2019 Apr; 125(7):1038-1049. PubMed ID: 30548240
[TBL] [Abstract][Full Text] [Related]
16. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients.
Zhou W; Heist RS; Liu G; Park S; Neuberg DS; Asomaning K; Wain JC; Lynch TJ; Christiani DC
Lung Cancer; 2006 Sep; 53(3):375-80. PubMed ID: 16814423
[TBL] [Abstract][Full Text] [Related]
17. A comparison study of clinicopathologic characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) patients by smoking status.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2010 Feb; 5(2):158-68. PubMed ID: 20040896
[TBL] [Abstract][Full Text] [Related]
18. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
19. A Decade of Never-smokers Among Lung Cancer Patients-Increasing Trend and Improved Survival.
Toh CK; Ong WS; Lim WT; Tan DS; Ng QS; Kanesvaran R; Seow WJ; Ang MK; Tan EH
Clin Lung Cancer; 2018 Sep; 19(5):e539-e550. PubMed ID: 29627315
[TBL] [Abstract][Full Text] [Related]
20. Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis.
Sohn HS; Kwon JW; Shin S; Kim HS; Kim H
J Clin Pharm Ther; 2015 Dec; 40(6):661-71. PubMed ID: 26573867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
